Atlas Trials

A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Clinical trial NCT04430855 · COMPLETED

Trial details

NCT number
NCT04430855
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa (HS)
Start date
2020-07-14
Primary completion
2021-04-22
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.